- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Daily deal net: February 24, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 24, 2021Shield AI screens $90m series C
Point72 Ventures has led a $90m series C round for Shield AI, whose leadership includes Carnegie Mellon University’s associate research professor Nathan Michael.
Feb 24, 2021Xylowatt runs out of steam
UCLouvain spinout Xylowatt has declared bankruptcy after failing to build a market for its technology to convert biomass into energy.
Feb 24, 2021Daily deal net: February 23, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 23, 2021Azeria reaches the end of the line
Azeria Therapeutics has wound down voluntarily four years after being set up to advance University of Cambridge and Cancer Research UK work.
Feb 23, 2021Nearpod approaches Renaissance Holding
Stanford-StartX Fund-backed Nearpod has agreed to an acquisition by Renaissance Holding.
Feb 23, 2021Boreal begins with $20m fund
Boreal Ventures will invest in deep tech companies emerging from ÉTS Montréal’s incubator Centech and the wider Quebec ecosystem.
Feb 23, 2021POI-Tech picks up $15.5m
South China University of Technology spinout POI-Tech is working on industrial internet applications and will use some of the money to expand R&D activities.
Feb 23, 2021Centessa circles $250m series A
Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.
Feb 23, 2021Artesian activates $79m fund
The firm has launched a fund and accelerator called Boab AI that will be run by Deakin University’s former ventures director Andrew Lai.
Feb 23, 2021Elicio elevates series B to $73m
MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.
Feb 22, 2021ImmuneID tackles $17m round
Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.
Feb 22, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


